DRUG(DRUG)
DRUG
Insider Transactions
Buys (12mo)
0
Sells (12mo)
1
Buy Value (12mo)
--
Net (12mo)
-$9.79M
| Date | Insider | Title | Type | Price | Shares | Value | Owned After |
|---|---|---|---|---|---|---|---|
| Apr 28, 26 | Cormorant Asset Management, LP | 10% Owner | Sale | $89.50 | 109.33K | $9.79M | 950.00K |
| Nov 4, 24 | Cormorant Asset Management, LP | 10 percent owner | Purchase | $21.70 | 184.33K | $4.00M | 1.06M |
| Oct 16, 24 | Cormorant Asset Management, LP | 10 percent owner | Purchase | $25.22 | 3.11K | $78.36K | 875.00K |
| Oct 16, 24 | Cormorant Asset Management, LP | 10 percent owner | Purchase | $24.03 | 7.15K | $171.81K | 871.89K |
| Oct 16, 24 | Cormorant Asset Management, LP | 10 percent owner | Purchase | $23.22 | 39.74K | $922.63K | 864.74K |
| Oct 15, 24 | Cormorant Asset Management, LP | 10 percent owner | Purchase | $12.35 | 4.61K | $56.93K | 825.00K |
| Oct 15, 24 | Cormorant Asset Management, LP | 10 percent owner | Purchase | $11.72 | 19.17K | $224.60K | 820.39K |
| Oct 15, 24 | Cormorant Asset Management, LP | 10 percent owner | Purchase | $9.26 | 2.70K | $25.01K | 801.22K |
| Oct 15, 24 | Cormorant Asset Management, LP | 10 percent owner | Purchase | $8.80 | 2.60K | $22.89K | 798.52K |
| Oct 15, 24 | Cormorant Asset Management, LP | 10 percent owner | Purchase | $7.31 | 8.90K | $65.02K | 795.92K |
| Oct 15, 24 | Cormorant Asset Management, LP | 10 percent owner | Purchase | $6.42 | 33.34K | $214.22K | 787.02K |
| Oct 15, 24 | Cormorant Asset Management, LP | 10 percent owner | Purchase | $5.92 | 63.17K | $374.24K | 753.68K |
| Oct 15, 24 | Cormorant Asset Management, LP | 10 percent owner | Purchase | $4.53 | 238.10K | $1.08M | 690.51K |
| Oct 15, 24 | Cormorant Asset Management, LP | 10 percent owner | Sale | -- | -- | -- | 452.41K |
Explore More
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Strategy Focus List
Continuous multi-factor scoring & catalyst forensics
Market Movers
Today's biggest gainers and losers